PLRXPliant Therapeutics, Inc.

$82M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-42.5% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$28M-2258.7% margin

Net Income

-$28M-2249.8% margin

EPS (Diluted)

$-0.77

QoQ Revenue Growth

-37.5%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$21M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$197M

Total Liabilities

$23M

Stockholders' Equity

$174M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$2M	-42.5%
Gross Profit	$1M	$2M	-42.5%
Operating Income	-$28M	-$23M	-23.1%
Net Income	-$28M	-$23M	-22.9%

PLRX Q1 2022 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena